Hydravax Recalled Due to Undeclared Ingredient
IQ Formulations initiated a precautionary and proactive recall of Hydravax dietary supplement due to a possible undeclared ingredient. An FDA analysis of one lot of Hydravax showed the presence of a diuretic, a prescription ingredient.
The use of a diuretic can lead to electrolyte imbalance due to water loss. Symptoms may include polyuria, nausea, vomiting, weakness, lassitude, fever, flushed face, and hyperactive deep tendon reflexes.
Excessive doses may lead to hyperkalemia, dehydration, nausea, vomiting, weakness, and possibly hypotension. Overdosing with a diuretic has been associated with hypokalemia, hypochloremia, hyponatremia, dehydration, lethargy, and gastrointestinal irritation.
Hydravax capsules are supplied in 45-count bottles.
Production of Hydravax has been suspended while IQ Formulations continues to investigate the source of the potential unlisted ingredient. All consumers who have purchased Hydravax are recommended to return them for a full refund.
For more information call (800) 626-1022 or visit the FDA Safety Alert page.